Cargando…
Tocilizumab: History and Future Perspectives in the Era of COVID-19
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804467/ http://dx.doi.org/10.1016/j.jaci.2021.12.642 |
_version_ | 1784643078013845504 |
---|---|
author | Modha, Rina Novack, Stuart |
author_facet | Modha, Rina Novack, Stuart |
author_sort | Modha, Rina |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8804467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Mosby, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88044672022-02-01 Tocilizumab: History and Future Perspectives in the Era of COVID-19 Modha, Rina Novack, Stuart J Allergy Clin Immunol Article Published by Mosby, Inc. 2022-02 2022-02-01 /pmc/articles/PMC8804467/ http://dx.doi.org/10.1016/j.jaci.2021.12.642 Text en Copyright © 2021 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Modha, Rina Novack, Stuart Tocilizumab: History and Future Perspectives in the Era of COVID-19 |
title | Tocilizumab: History and Future Perspectives in the Era of COVID-19 |
title_full | Tocilizumab: History and Future Perspectives in the Era of COVID-19 |
title_fullStr | Tocilizumab: History and Future Perspectives in the Era of COVID-19 |
title_full_unstemmed | Tocilizumab: History and Future Perspectives in the Era of COVID-19 |
title_short | Tocilizumab: History and Future Perspectives in the Era of COVID-19 |
title_sort | tocilizumab: history and future perspectives in the era of covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804467/ http://dx.doi.org/10.1016/j.jaci.2021.12.642 |
work_keys_str_mv | AT modharina tocilizumabhistoryandfutureperspectivesintheeraofcovid19 AT novackstuart tocilizumabhistoryandfutureperspectivesintheeraofcovid19 |